🔴 NuCana is trading 5% down amid broader biotech weakness

NuCana is trading at $1.07 (-5.31%) on October 9, 2026, with sector pressure a possible factor.

• Biotech ETF XBI fell 2.04%, though that does not fully explain NuCana’s larger decline.
• No clear company-specific catalyst was identified; NuCana’s official news page lists no October 9 announcement.
• Available evidence points to sector pressure, not a confirmed company-specific event.